Everytime I see their rating on this stock it's "Strong Buy!!" they had a SB before Zingo was recalled and now..their only drug being out of the market and it doesn't change ANYTHING from their analysis? Sorry, no matter how much you believe in Adlea it's still a drug that has not been approved and still in testing. Marketability has yet to be demonstrated.

At this point, this is a HIGHLY speculative pick and the constant Strong Buy rec'd from Zacks for a company without a product on the market leads me to wonder if something is up here.